• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCR5氨基末端结构域中极性和非极性残基的丙氨酸取代对1型人类免疫缺陷病毒的巨噬细胞嗜性和双嗜性分离株的进入有不同程度的损害。

Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1.

作者信息

Rabut G E, Konner J A, Kajumo F, Moore J P, Dragic T

机构信息

Aaron Diamond AIDS Research Center, The Rockefeller University, New York, New York 10016, USA.

出版信息

J Virol. 1998 Apr;72(4):3464-8. doi: 10.1128/JVI.72.4.3464-3468.1998.

DOI:10.1128/JVI.72.4.3464-3468.1998
PMID:9525683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC109856/
Abstract

Multiple extracellular domains of the CC-chemokine receptor CCR5 are important for its function as a human immunodeficiency virus type 1 (HIV-1) coreceptor. We have recently demonstrated by alanine scanning mutagenesis that the negatively charged residues in the CCR5 amino-terminal domain are essential for gp120 binding and coreceptor function. We have now extended our analysis of this domain to include most polar and nonpolar amino acids. Replacement of alanine with all four tyrosine residues and with serine-17 and cysteine-20 decrease or abolish gp120 binding and CCR5 coreceptor activity. Tyrosine-15 is essential for viral entry irrespective of the test isolate. Substitutions at some of the other positions impair the entry of dualtropic HIV-1 isolates more than that of macrophagetropic ones.

摘要

CC趋化因子受体CCR5的多个细胞外结构域对其作为1型人类免疫缺陷病毒(HIV-1)共受体的功能至关重要。我们最近通过丙氨酸扫描诱变证明,CCR5氨基末端结构域中的带负电荷残基对于gp120结合和共受体功能至关重要。我们现在已将对该结构域的分析扩展至包括大多数极性和非极性氨基酸。用所有四个酪氨酸残基以及丝氨酸-17和半胱氨酸-20取代丙氨酸会降低或消除gp120结合和CCR5共受体活性。无论测试分离株如何,酪氨酸-15对于病毒进入都是必不可少的。其他一些位置的取代对双嗜性HIV-1分离株进入的损害比对巨噬细胞嗜性分离株的损害更大。

相似文献

1
Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1.CCR5氨基末端结构域中极性和非极性残基的丙氨酸取代对1型人类免疫缺陷病毒的巨噬细胞嗜性和双嗜性分离株的进入有不同程度的损害。
J Virol. 1998 Apr;72(4):3464-8. doi: 10.1128/JVI.72.4.3464-3468.1998.
2
Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry.CCR5 共受体中的氨基末端取代会损害 gp120 结合及 1 型人类免疫缺陷病毒的进入。
J Virol. 1998 Jan;72(1):279-85. doi: 10.1128/JVI.72.1.279-285.1998.
3
CCR5-Mediated human immunodeficiency virus entry depends on an amino-terminal gp120-binding site and on the conformational integrity of all four extracellular domains.CCR5介导的人类免疫缺陷病毒进入依赖于一个氨基末端gp120结合位点以及所有四个细胞外结构域的构象完整性。
J Virol. 1999 Feb;73(2):1645-8. doi: 10.1128/JVI.73.2.1645-1648.1999.
4
Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.CCR5单克隆抗体对1型人类免疫缺陷病毒融合、gp120结合及CC趋化因子活性的差异性抑制作用
J Virol. 1999 May;73(5):4145-55. doi: 10.1128/JVI.73.5.4145-4155.1999.
5
Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein.CCR5氨基末端结构域中的多个带电荷和芳香族残基参与趋化因子和HIV-1包膜蛋白的高亲和力结合。
J Biol Chem. 1999 Dec 3;274(49):34719-27. doi: 10.1074/jbc.274.49.34719.
6
Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses.非洲绿猴和小鼠CCR5基因的多态性表明特定氨基酸与猿类免疫缺陷病毒和人类免疫缺陷病毒感染有关。
J Virol. 1997 Nov;71(11):8642-56. doi: 10.1128/JVI.71.11.8642-8656.1997.
7
Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.V3独立结构域在双嗜性1型人类免疫缺陷病毒(HIV-1)包膜糖蛋白gp120利用CCR5共受体及病毒感染性方面的作用
Microbiol Immunol. 2001;45(7):521-30. doi: 10.1111/j.1348-0421.2001.tb02653.x.
8
Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.鉴定1型双嗜性人类免疫缺陷病毒包膜糖蛋白上决定使用CXCR4的决定簇。
J Virol. 1998 Mar;72(3):2509-15. doi: 10.1128/JVI.72.3.2509-2515.1998.
9
CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates.非B亚型1型人类免疫缺陷病毒原始分离株对CCR5和CXCR4的利用情况
J Virol. 2002 Mar;76(6):3059-64. doi: 10.1128/jvi.76.6.3059-3064.2002.
10
Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120.含磺基酪氨酸的CCR5氨基末端结构域肽与HIV-1包膜糖蛋白gp120的特异性相互作用。
Proc Natl Acad Sci U S A. 2000 May 23;97(11):5762-7. doi: 10.1073/pnas.97.11.5762.

引用本文的文献

1
Integrating deep mutational scanning and low-throughput mutagenesis data to predict the impact of amino acid variants.整合深度突变扫描和低通量诱变数据来预测氨基酸变异的影响。
Gigascience. 2022 Dec 28;12. doi: 10.1093/gigascience/giad073. Epub 2023 Sep 18.
2
Deep Mutational Scanning of Viral Glycoproteins and Their Host Receptors.病毒糖蛋白及其宿主受体的深度突变扫描
Front Mol Biosci. 2021 Apr 9;8:636660. doi: 10.3389/fmolb.2021.636660. eCollection 2021.
3
[CCR5 antagonists and HIV-1 infection: Bases and consequences of this therapeutic approach].[CCR5拮抗剂与HIV-1感染:这种治疗方法的基础与后果]
Antibiotiques (Paris). 2010 Mar;12(1):27-41. doi: 10.1016/j.antib.2010.01.006. Epub 2010 Feb 18.
4
Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning.通过深度突变扫描绘制人类趋化因子受体的相互作用位点。
J Immunol. 2018 Jun 1;200(11):3825-3839. doi: 10.4049/jimmunol.1800343. Epub 2018 Apr 20.
5
Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.CC趋化因子受体5与强效趋化因子拮抗剂的结构揭示了趋化因子识别机制及HIV的分子模拟机制。
Immunity. 2017 Jun 20;46(6):1005-1017.e5. doi: 10.1016/j.immuni.2017.05.002.
6
C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection.C-C趋化因子受体5型(CCR5):控制HIV感染的一个新靶点。
Appl Transl Genom. 2013 May 26;2:3-16. doi: 10.1016/j.atg.2013.05.004. eCollection 2013 Dec 1.
7
Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5.阐明一个关键的抗HIV-1和癌症相关轴:CCL5(趋化因子调节激活正常T细胞表达和分泌因子)与CCR5复合物的结构
Sci Rep. 2014 Jun 26;4:5447. doi: 10.1038/srep05447.
8
Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.HIV-1 gp120 V3环对CCR5的分子识别。
PLoS One. 2014 Apr 24;9(4):e95767. doi: 10.1371/journal.pone.0095767. eCollection 2014.
9
Susceptibility of HIV type 2 primary isolates to CCR5 and CXCR4 monoclonal antibodies, ligands, and small molecule inhibitors.2型人类免疫缺陷病毒原始分离株对CCR5和CXCR4单克隆抗体、配体及小分子抑制剂的敏感性。
AIDS Res Hum Retroviruses. 2012 May;28(5):478-85. doi: 10.1089/AID.2011.0124. Epub 2011 Oct 3.
10
The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide.一个 27 残基的 CCR5 肽与 HIV-1 gp120 和一个 CD4 模拟肽形成的三元复合物的构象和取向。
J Mol Biol. 2011 Jul 29;410(5):778-97. doi: 10.1016/j.jmb.2011.04.023.

本文引用的文献

1
Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry.CCR5 共受体中的氨基末端取代会损害 gp120 结合及 1 型人类免疫缺陷病毒的进入。
J Virol. 1998 Jan;72(1):279-85. doi: 10.1128/JVI.72.1.279-285.1998.
2
Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.趋化因子受体CCR5与其配体的相互作用:HIV-1 gp120结合的多个结构域和趋化因子结合的单个结构域。
J Exp Med. 1997 Oct 20;186(8):1373-81. doi: 10.1084/jem.186.8.1373.
3
Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection.在CD4阳性细胞中表达的两种孤儿七跨膜片段受体支持猿猴免疫缺陷病毒感染。
J Exp Med. 1997 Aug 4;186(3):405-11. doi: 10.1084/jem.186.3.405.
4
Expression cloning of new receptors used by simian and human immunodeficiency viruses.猿猴免疫缺陷病毒和人类免疫缺陷病毒所使用的新受体的表达克隆
Nature. 1997 Jul 17;388(6639):296-300. doi: 10.1038/40894.
5
A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-1(89.6) but not the T-tropic isolate HIV-1(HxB).一种针对CXCR-4的单克隆抗体(12G5)可抑制双嗜性人类免疫缺陷病毒1型分离株HIV-1(89.6)的感染,但不能抑制嗜T细胞性分离株HIV-1(HxB)的感染。
J Virol. 1997 Jul;71(7):5678-83. doi: 10.1128/JVI.71.7.5678-5683.1997.
6
Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion.CCR-5的多个细胞外结构域有助于1型人类免疫缺陷病毒的进入和融合。
J Virol. 1997 Jul;71(7):5003-11. doi: 10.1128/JVI.71.7.5003-5011.1997.
7
HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor.HIV-1诱导的细胞融合由病毒包膜和CCR-5共受体中的多个区域介导。
EMBO J. 1997 May 15;16(10):2599-609. doi: 10.1093/emboj/16.10.2599.
8
STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1.STRL33,一种新型趋化因子受体样蛋白,作为巨噬细胞嗜性和T细胞系嗜性HIV-1的融合辅助因子发挥作用。
J Exp Med. 1997 Jun 2;185(11):2015-23. doi: 10.1084/jem.185.11.2015.
9
Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity.CXCR-4的第一和第三个细胞外结构域在人类免疫缺陷病毒共受体活性中的作用。
J Virol. 1997 Jun;71(6):4744-51. doi: 10.1128/JVI.71.6.4744-4751.1997.
10
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.HIV共受体CXCR4和CCR5在人类T淋巴细胞上的表达和调控存在差异。
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1925-30. doi: 10.1073/pnas.94.5.1925.